Genetic deficiency of Nrf2 can down-regulate the expression of system xc- through the Nrf2-Keap1 pathway, leading to erastin-induced ROS accumulation in glioma cells and increasing the sensitivity of cells to ferroptosis (Fan et al., 2017). The gene discussed is NFE2L2; the disease is central nervous system cancer.